BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28819773)

  • 21. Clinical significance of hWAPL polymorphisms in the risk of cervical carcinogenesis.
    Nunobiki O; Sano D; Hata S; Ogasawara T; Ueda M
    Hum Cell; 2018 Apr; 31(2):149-153. PubMed ID: 29362984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCL12 rs266085 and TNF-α rs1799724 polymorphisms and susceptibility to cervical cancer in a Chinese population.
    Yin G; Zhu T; Li J; Wu A; Liang J; Zhi Y
    Int J Clin Exp Pathol; 2015; 8(5):5768-74. PubMed ID: 26191295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians.
    Hamdy S; Osman AM; Zakaria ZA; Galal I; Sobhy M; Hashem M; Allam WR; Abdel-Samiee M; Rewisha E; Waked I; Abdelwahab SF
    Arch Virol; 2018 Sep; 163(9):2433-2442. PubMed ID: 29860675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MMP-9/RECK Imbalance: A Mechanism Associated with High-Grade Cervical Lesions and Genital Infection by Human Papillomavirus and Chlamydia trachomatis.
    Discacciati MG; Gimenes F; Pennacchi PC; Faião-Flores F; Zeferino LC; Derchain SM; Teixeira JC; Costa MC; Zonta M; Termini L; Boccardo E; Longatto-Filho A; Consolaro ME; Villa LL; Maria-Engler SS
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1539-47. PubMed ID: 26261088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Relationship of the TLR9 and TLR2 Genetic Polymorphisms with Cervical Cancer Risk: a Meta-Analysis of Case-Control Studies.
    Yang S; Liu L; Xu D; Li X
    Pathol Oncol Res; 2020 Jan; 26(1):307-315. PubMed ID: 30215163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation in human papillomavirus-infected cervical cells is elevated in high-grade squamous intraepithelial lesions and cancer.
    Kim MK; Lee IH; Lee KH; Lee YK; So KA; Hong SR; Hwang CS; Kee MK; Rhee JE; Kang C; Hur SY; Park JS; Kim TJ
    J Gynecol Oncol; 2016 Mar; 27(2):e14. PubMed ID: 26768780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms in Toll-like receptors genes changes the host's immune response and is associated with cervical cancer.
    Moura EL; Santos IFD; Freitas PP; Silva DMD; Santos ACMD; Lira Neto AB; Silva ACPE; Barbosa NR; Nascimento CA; Balliano TL; Fraga CAC; Farias KF; Figueiredo EVMS
    Immunobiology; 2022 Mar; 227(2):152187. PubMed ID: 35158151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
    Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The protective role of the -1306C>T functional polymorphism in matrix metalloproteinase-2 gene is associated with cervical cancer: implication of human papillomavirus infection.
    Singh N; Hussain S; Sharma U; Suri V; Nijhawan R; Bharadwaj M; Sobti RC
    Tumour Biol; 2016 Apr; 37(4):5295-303. PubMed ID: 26561467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression Profile of MicroRNA-203 and its ΔNp63 Target in Cervical Carcinogenesis: Prospects for Cervical Cancer Screening.
    Coimbra EC; DA Conceição Gomes Leitão M; Júnior MR; DE Oliveira TH; DA Costa Silva Neto J; DE Freitas AC
    Anticancer Res; 2016 Aug; 36(8):3939-46. PubMed ID: 27466497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
    Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
    Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
    Učakar V; Poljak M; Oštrbenk A; Klavs I
    J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of human papillomavirus genotypes in Paraguayan women according to the severity of the cervical lesion.
    Mendoza LP; Arbiza J; Paez M; Kasamatsu E; Castro A; Giménez G; Basiletti J; Gonzalez J; Mongelós P; Picconi MA
    J Med Virol; 2011 Aug; 83(8):1351-7. PubMed ID: 21618554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesions of the uterine cervix with human papilloma virus infection among young women aged less than 25 years.
    Ryu KJ; Lee S; Min KJ; Hong JH; Song JY; Lee JK; Lee NW
    Diagn Cytopathol; 2016 Dec; 44(12):959-963. PubMed ID: 27714942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical Squamous Cells in Liquid-Based Cervical Cytology: Microbiology, Inflammatory Infiltrate, and Human Papillomavirus-DNA Testing.
    Gomes de Oliveira G; Eleutério RMN; Silveira Gonçalves AK; Giraldo PC; Eleutério J
    Acta Cytol; 2018; 62(1):28-33. PubMed ID: 29130974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.
    Zidi S; Verdi H; Yilmaz-Yalcin Y; Yazici AC; Gazouani E; Mezlini A; Atac FB; Yacoubi-Loueslati B
    Bull Cancer; 2014 Oct; 101(10):E31-5. PubMed ID: 25373689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility.
    Pandey S; Mittal B; Srivastava M; Singh S; Srivastava K; Lal P; Mittal RD
    Mol Biol Rep; 2011 Oct; 38(7):4715-21. PubMed ID: 21132533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of human papillomavirus 16 E6 variants with cervical carcinoma and precursor lesions in women from Southern Mexico.
    Ortiz-Ortiz J; Alarcón-Romero Ldel C; Jiménez-López MA; Garzón-Barrientos VH; Calleja-Macías I; Barrera-Saldaña HA; Leyva-Vázquez MA; Illades-Aguiar B
    Virol J; 2015 Feb; 12():29. PubMed ID: 25889023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BORIS and CTCF are overexpressed in squamous intraepithelial lesions and cervical cancer.
    Velázquez-Hernández N; Reyes-Romero MA; Barragán-Hernández M; Guerrero-Romero F; Rodríguez-Moran M; Aguilar-Durán M; Lazalde Medina B
    Genet Mol Res; 2015 Jun; 14(2):6094-100. PubMed ID: 26125810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.